Elanco Animal Health (ELAN) Long-Term Debt Repayments (2019 - 2021)
Elanco Animal Health's (ELAN) quarterly Long-Term Debt Repayments came in at $518.0 million in Q3 2021, up 69.28% year-on-year from $306.0 million in Q3 2020, and up 2947.06% quarter-over-quarter from $17.0 million in Q2 2021.
Elanco Animal Health (ELAN) Long-Term Debt Repayments (2019 - 2021) Analysis & Trends
Elanco Animal Health has disclosed Long-Term Debt Repayments across 3 years of filings, most recently posting $518.0 million for Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | LT Debt Repayment (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 23.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 216,000.00 |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | 19.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2021 | 518.00 Mn |
| Sep 30, 2021 | 518.00 Mn |
| Jun 30, 2021 | 17.00 Mn |
| Jun 30, 2021 | 17.00 Mn |
| Mar 31, 2021 | 20.00 Mn |
| Mar 31, 2021 | 20.00 Mn |
| Sep 30, 2020 | 306.00 Mn |
| Sep 30, 2020 | 306.00 Mn |
| Jun 30, 2020 | 7.00 Mn |
| Jun 30, 2020 | 7.00 Mn |
| Mar 31, 2020 | 371.00 Mn |
| Mar 31, 2020 | 371.00 Mn |
| Sep 30, 2019 | 50.00 Mn |
| Sep 30, 2019 | 50.00 Mn |
| Jun 30, 2019 | 57.50 Mn |
| Jun 30, 2019 | 57.50 Mn |
| Mar 31, 2019 | 7.50 Mn |
| Mar 31, 2019 | 7.50 Mn |